Warrington and Halton Hospitals

Stroke research studies


We are recruiting for two studies within stroke:

FOCUS

The overall aim of our research is to find out whether fluoxetine improves recovery if given to stroke survivors who are between 2 and 15 days after the onset of their stroke, and who still have residual problems such as a weak arm, weak leg or language problems. We will also find out whether it helps the stroke survivor overcome weakness, communication difficulties or fatigue. We will do this by performing a large randomised trial in the UK, recruiting approximately 3000 patients. Half the patients will be randomly allocated fluoxetine for 6 months, and the other half will receive a placebo pill. For patients who cannot swallow, we will give the drug or a matching placebo through their feeding tube. Patients will be followed up at 6 months, and then at 12 months, to see whether any benefits persist long-term.


IVIS

Visual problems can occur in three quarters of stroke survivors and this can have an impact on quality of life. There are 4 main types of visual problem which are: central vision loss, visual field loss, eye movement problems and visual processing problems. This new stroke study is called IVIS – impact of visual impairment after stroke. Patients are given a cognitive screen to complete and are asked to complete a questionnaire. Following this a referral may be made for further assessment if necessary.

Contact Us

Phone numbers and email enquiry contacts.

How to find us

Maps, directions and transport.

Our hospital magazine

Read our Your Hospitals magazine

Transparency

Key information on quality and safety.